Corticosteroids Market
Global Corticosteroids Market Size, Share & Trends Analysis Report, By Product (Glucocorticoids and Mineralocorticoids), By Route of Administration (Topical, Inhaled, Oral, Systemic, and Others), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Gastroenterology, and Others) and Forecast, 2020-2026
The global corticosteroids market is estimated to grow at a CAGR of nearly 4.8% during the forecast period. The major factors contributing to the market growth include the rising incidences of chronic diseases and increasing demand for inhaled and topical corticosteroids. There is a significant rise in the prevalence of chronic diseases, including acute respiratory diseases and rheumatic disorders. The most common chronic respiratory diseases include asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and occupational lung diseases. As per the World Health Organization (WHO), in 2016, over 339 million people were suffering from asthma across the globe and is a common condition among children.
Additionally, in 2016, nearly 251 million people were suffering from COPD across the globe. COPD is anticipated to increase in the future coupled with the considerable prevalence of smoking and aging populations in several countries. The rising prevalence of asthma and COPD has led the demand for inhaled corticosteroids for the management of the condition. These are anti-inflammatory drugs which is most commonly used as an effective long-term control medication for asthma. It enables to decrease swelling and tightening in airways.
Some inhaled corticosteroids that are used for the treatment of asthma include Ciclesonide (Alvesco), Fluticasone (Flovent HFA), Beclomethasone (Qvar RediHaler), Budesonide (Pulmicort Flexhaler), and Mometasone (Asmanex Twisthaler). Inhaled corticosteroids don't usually cause severe side effects. The side-effects may include oral yeast infections and mouth and throat irritation. This rising incidence of chronic respiratory diseases is primarily encouraging the demand for inhaled corticosteroids, which in turn, is driving the growth of the market. Emerging strong pipeline medications of corticosteroids for the treatment of several conditions will likely offer an opportunity for the market growth.
Market Segmentation
The global corticosteroids market is segmented based on product, route of administration, and application. Based on product, the market is classified into glucocorticoids and mineralocorticoids. Based on route of administration, the market is classified into topical, inhaled, oral, systemic, and others. Based on application, the market is classified into skin allergies, rheumatology indications, endocrinology, acute respiratory diseases, gastroenterology, and others.
Glucocorticoids finds its significant application in the treatment of multiple conditions
Glucocorticoids are potential drugs that are significantly used for the treatment of autoimmune and inflammatory diseases. The body makes its own glucocorticoids hormones that performs controlling the use of sugar and fat by cells and curbing inflammation. Glucocorticoids supports to keep the body pumping out several chemicals that are involved in inflammation. Owing to its better inflammatory properties, glucocorticoids are being significantly used for the treatment of several conditions caused by inflammation. These conditions include asthma, COPD, osteoarthritis, rheumatoid arthritis, allergies, inflammatory bowel disease, and multiple sclerosis. Glucocorticoids is also prescribed for patients who get organ transplants. Glucocorticoids were among the first drug classes which is utilized to prevent organ rejection after transplantation procedure. The two glucocorticoids medications that are used frequently after solid organ transplantation as part of the immunosuppressive regimen include prednisone and methylprednisolone.
Global Corticosteroids Market Share by Product, 2019 (%)
Regional Outlook
Geographically, the market is classified into North America, Europe, Asia-Pacific, and Rest of the World. In 2019, North America is anticipated to hold significant share in the market owing to the significant prevalence of chronic diseases and rising demand for organ transplantation in the region. As per the Division of Transplantation within the Health Resources and Services Administration, in 2019, there were 39,718 transplants performed in the US. In 2019, over 112,000 men, women, and children were waiting for organ transplantation in the US.
The total number of donors was 19,267, of which 7,397 were living donors and 11,870 were deceased donors. There is an increased risk of organ rejection after solid transplantation procedure, which leads to the increasing adoption of glucocorticoids to prevent such conditions. Asia-Pacific is estimated to witness considerable growth during the forecast period owing to the rising geriatric population and increasing prevalence of chronic respiratory disorders due to air pollution and increasing number of patients with skin allergies in the region.
Global Corticosteroids Market Growth, by Region 2020-2026
Market Players Outlook
The major players operating in the market include Novartis International AG, Pfizer Inc., Merck & Co., Inc., AstraZeneca plc, and GlaxoSmithKline plc. The strategies adopted by the market players include mergers and acquisitions, product launches, and partnerships and collaborations to expand market share and gain a competitive advantage. For instance, in May 2018, GlaxoSmithKline declared the approval from the US FDA for the use of Arnuity Ellipta (fluticasone furoate). It is an inhaled corticosteroid drug for the maintenance treatment of asthma among children from 5 years old. With this approval, Arnuity becomes one of the few available once-daily treatments for asthma in the US for the younger age group. As there is a significant need for convenient and potential treatment options for younger children in the US, the introduction of this new inhaled corticosteroids will support the company to increase its market share.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global corticosteroids market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Novartis International AG
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Merck & Co., Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. AstraZeneca plc
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Pfizer Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. GlaxoSmithKline plc
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Corticosteroids Market by Product
5.1.1. Glucocorticoids
5.1.2. Mineralocorticoids
5.2. Global Corticosteroids Market by Route of Administration
5.2.1. Topical
5.2.2. Inhaled
5.2.3. Oral
5.2.4. Systemic
5.2.5. Others
5.3. Global Corticosteroids Market by Application
5.3.1. Skin Allergies
5.3.2. Rheumatology Indications
5.3.3. Endocrinology
5.3.4. Acute Respiratory Diseases
5.3.5. Gastroenterology
5.3.6. Others
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Actiza Pharmaceutical Pvt. Ltd.
7.2. Amgen Inc.
7.3. Aspen Pharmacare Holdings Ltd.
7.4. AstraZeneca plc
7.5. Bristol Myers Squibb Co.
7.6. Cipla Ltd.
7.7. Fresenius Kabi AG
7.8. GlaxoSmithKline plc
7.9. Hovione FarmaCiencia SA
7.10. Lupin Ltd.
7.11. Merck & Co., Inc.
7.12. Mylan N.V.
7.13. Novartis International AG
7.14. Pfizer Inc.
7.15. Sanofi S.A.
7.16. Teva Pharmaceutical Industries Ltd.
7.17. West Ward Pharmaceuticals
1. GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2019-2026 ($ MILLION)
2. GLOBAL GLUCOCORTICOIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL MINERALOCORTICOIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
5. GLOBAL TOPICAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL INHALED CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL ORAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
8. GLOBAL SYSTEMIC CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. GLOBAL OTHER CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
11. GLOBAL CORTICOSTEROIDS IN SKIN ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
12. GLOBAL CORTICOSTEROIDS IN RHEUMATOLOGY INDICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
13. GLOBAL CORTICOSTEROIDS IN ENDOCRINOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
14. GLOBAL CORTICOSTEROIDS IN ACUTE RESPIRATORY DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
15. GLOBAL CORTICOSTEROIDS IN GASTROENTEROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
16. GLOBAL CORTICOSTEROIDS IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
17. GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
18. NORTH AMERICAN CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
19. NORTH AMERICAN CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2019-2026 ($ MILLION)
20. NORTH AMERICAN CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
21. NORTH AMERICAN CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
22. EUROPEAN CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
23. EUROPEAN CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2019-2026 ($ MILLION)
24. EUROPEAN CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
25. EUROPEAN CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
26. ASIA-PACIFIC CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
27. ASIA-PACIFIC CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2019-2026 ($ MILLION)
28. ASIA-PACIFIC CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
29. ASIA-PACIFIC CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
30. REST OF THE WORLD CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2019-2026 ($ MILLION)
31. REST OF THE WORLD CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
32. REST OF THE WORLD CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
1. GLOBAL CORTICOSTEROIDS MARKET SHARE BY PRODUCT, 2019 VS 2026 (%)
2. GLOBAL CORTICOSTEROIDS MARKET SHARE BY ROUTE OF ADMINISTRATION, 2019 VS 2026 (%)
3. GLOBAL CORTICOSTEROIDS MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
4. GLOBAL CORTICOSTEROIDS MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
5. US CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
6. CANADA CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
7. UK CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
8. FRANCE CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
9. GERMANY CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
10. ITALY CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
11. SPAIN CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
12. ROE CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
13. INDIA CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
14. CHINA CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
15. JAPAN CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF ASIA-PACIFIC CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
17. REST OF THE WORLD CORTICOSTEROIDS MARKET SIZE, 2019-2026 ($ MILLION)
